Metabolic syndrome [dsyn]
postmenopausal [tmco]
Women [popg]
influential [idcn]
Oral [spco]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Inflammation [patf]
Coagulation [ortf]
Marker [clna]
Objective [inpr]
Objective [inpr]
Study [mnob]
To [qlco]
ROUTE [ftcn]
Administration [ocac]
estrogen therapy [topp]
Women [popg]
Metabolic syndrome [dsyn]
Inflammation [patf]
Coagulation [ortf]
Parameters [fndg]
Study Design [resa]
Symptomatic [ftcn]
postmenopausal [tmco]
Women [popg]
Metabolic syndrome [dsyn]
randomized [resa]
To [qlco]
Receive [qlco]
mg% [qnco]
Oral [spco]
Estradiol [horm, phsu, strd]
Oe [qnco]
Transdermal [ftcn]
measurements [ftcn]
Compared [acty]
Health [idcn]
premenopausal [tmco]
Women [popg]
Normal [qlco]
postmenopausal [tmco]
Women [popg]
Result [ftcn]
Compared [acty]
Control Groups [grup]
Women [popg]
Metabolic syndrome [dsyn]
High [qlco]
Levels [qlco]
Certain [qlco]
Inflammation [patf]
Coagulation [ortf]
Marker [clna]
account [idcn]
Based [ftcn]
weight [orga]
Alone [qnco]
Antithrombin III [aapp, phsu]
Decreased [qnco]
P NOS [aapp, imft]
metalloproteinase inhibitor [moft]
Tissue [tisu]
Metalloproteinase [aapp, enzy]
Ratio [qnco]
Increased [qnco]
P NOS [aapp, imft]
E-Selectin [aapp, imft, rcpt]
Decreased [qnco]
ng/mL [qnco]
P NOS [aapp, imft]
Te [elii, hops]
Major [qlco]
Note [clna]
Conclusion [idcn]
postmenopausal [tmco]
Women [popg]
Metabolic syndrome [dsyn]
High [qlco]
Levels [qlco]
Certain [qlco]
Coagulation [ortf]
Inflammation [patf]
Marker [clna]
Different [qlco]
responses [orga]
Oral [spco]
Compared [acty]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
